Literature DB >> 23406195

Tissue-regenerating functions of coagulation factor XIII.

C Soendergaard1, P H Kvist, J B Seidelin, O H Nielsen.   

Abstract

The protransglutaminase factor XIII (FXIII) has recently attracted attention within the field of tissue regeneration, as it has been found that FXIII significantly influences wound healing by exerting a multitude of functions. It supports hemostasis by enhancing platelet adhesion to damaged endothelium, and by its cross-linking activity it stabilizes the formed fibrin clot. Furthermore, FXIII limits bacterial dissemination from the wound and incorporates macromolecules of importance for cellular infiltration, supporting cell migration and survival. FXIII-mediated complex formation of the vascular endothelial growth factor receptor 2 and αV β3 integrin is important for angiogenesis, supporting the formation of granulation tissue. Chronic inflammatory conditions involving bleeding and activation of the coagulation cascade have been shown to lead to reduced FXIII levels in plasma. Of particular importance for this review is the fact that patients suffering from inflammatory bowel disease (IBD) have reduced FXIII antigen levels and activity. Furthermore, these patients show impaired mucosal healing, which supports the inflammatory state of the disease. This review summarizes the role of FXIII in the healing of wounds, and briefly summarizes the previous use of FXIII in clinical settings. Moreover, it addresses the potential role for FXIII as a therapeutic agent in the healing of persistent wounds during chronic conditions, with an emphasis on IBD.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406195     DOI: 10.1111/jth.12169

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  15 in total

1.  Effect of early administration of coagulation factor XIII on fistula after pancreatic surgery: the FIPS randomized controlled trial.

Authors:  Yoshinori Takeda; Yoshihiro Mise; Naoki Ishizuka; Sohei Harada; Brian Hayama; Yosuke Inoue; Takeaki Ishizawa; Hiromichi Ito; Yu Takahashi; Akio Saiura
Journal:  Langenbecks Arch Surg       Date:  2018-11-30       Impact factor: 3.445

Review 2.  Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

Authors:  Danuta Owczarek; Dorota Cibor; Mikołaj K Głowacki; Tomasz Rodacki; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients.

Authors:  Marina Marchetti; Patricia Gomez-Rosas; Laura Russo; Sara Gamba; Eleonora Sanga; Cristina Verzeroli; Chiara Ambaglio; Francesca Schieppati; Francesco Restuccia; Ezio Bonanomi; Marco Rizzi; Stefano Fagiuoli; Andrea D'Alessio; Grigorios T Gerotziafas; Luca Lorini; Anna Falanga
Journal:  Front Cardiovasc Med       Date:  2022-06-10

4.  Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes.

Authors:  Christoffer Soendergaard; Peter Helding Kvist; Jakob Benedict Seidelin; Hermann Pelzer; Ole Haagen Nielsen
Journal:  J Gastroenterol       Date:  2015-12-11       Impact factor: 7.527

5.  Thrombosis in inflammatory bowel diseases: what's the link?

Authors:  Martina Giannotta; Gherardo Tapete; Giacomo Emmi; Elena Silvestri; Monica Milla
Journal:  Thromb J       Date:  2015-04-02

6.  Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis.

Authors:  Christina Andersson; Peter H Kvist; Kathryn McElhinney; Richard Baylis; Luise K Gram; Hermann Pelzer; Brian Lauritzen; Thomas L Holm; Simon Hogan; David Wu; Brian Turpin; Whitney Miller; Joseph S Palumbo
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 7.  Advances of Coagulation Factor XIII.

Authors:  Da-Yu Shi; Shu-Jie Wang
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

8.  Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study.

Authors:  Karsten Bernerth; Ingolf Schiefke; Karin Liebscher; Susanne Raczynski; Tanja Kottmann; Niels Teich
Journal:  BMC Res Notes       Date:  2018-12-04

9.  Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement.

Authors:  Siyu Ma; Changming Chen; Qian Liang; Xi Wu; Xuefeng Wang; Wenman Wu; Yan Liu; Qiulan Ding
Journal:  Orphanet J Rare Dis       Date:  2019-07-24       Impact factor: 4.123

10.  Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation.

Authors:  Fahad S M Alshehri; Claire S Whyte; Ahmet Tuncay; Maria-Louise Williams; Heather M Wilson; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-06-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.